The drug already works for women with cancer fuelled by BRCA gene mutations
was led by researchers at the Institute of Cancer Research and the Royal Marsden hospital
Olaparib is the first cancer drug to target inherited genetic mutations
PARP inhibitors work by blocking the cancer cell 's ability to repair damage
Dr Emma Hall of the Institute of Cancer Research said
